Upadacitinib ameliorates joint inflammation and RA-associated muscle atrophy in a murine model in association with JAK-STAT pathway inhibition.

Shi H, Sun Y, Hong Z, Chen X

Open source

DOI
10.1016/j.tice.2026.104098
Published
2026 Oct 27
Container
Tissue & cell
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.tice.2026.104098,
  title = {Upadacitinib ameliorates joint inflammation and RA-associated muscle atrophy in a murine model in association with JAK-STAT pathway inhibition.},
  author = {Shi H and Sun Y and Hong Z and Chen X},
  year = {2026},
  journal = {Tissue \& cell},
  doi = {10.1016/j.tice.2026.104098},
  url = {https://doi.org/10.1016/j.tice.2026.104098}
}

RIS

TY  - JOUR
TI  - Upadacitinib ameliorates joint inflammation and RA-associated muscle atrophy in a murine model in association with JAK-STAT pathway inhibition.
AU  - Shi H
AU  - Sun Y
AU  - Hong Z
AU  - Chen X
PY  - 2026
JO  - Tissue & cell
DO  - 10.1016/j.tice.2026.104098
UR  - https://doi.org/10.1016/j.tice.2026.104098
ER  - 

APA

H, S., Y, S., Z, H., & X, C. (2026). Upadacitinib ameliorates joint inflammation and RA-associated muscle atrophy in a murine model in association with JAK-STAT pathway inhibition.. Tissue & cell. https://doi.org/10.1016/j.tice.2026.104098

Source records